Segmentectomy for roentgenographically occult bronchogenic squamous cell carcinoma

被引:20
作者
Sagawa, M
Koike, T
Sato, M
Oda, M
Kondo, T
Kato, H
Tsuchiya, R
机构
[1] Lung Cancer Surgical Study Group (LCSSG), Japanese Clinical Oncology Group (JCOG)
[2] Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Aoba-ku, Sendai 980-8575
关键词
D O I
10.1016/S0003-4975(00)02661-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Roentgenographically occult bronchogenic squamous cell carcinomas (ROSCCs) are early squamous cell lung cancers of central type. Some of them cannot be treated with intrabronchial therapy. Although surgical treatment was performed for such tumors, it was unknown whether lobectomy was indispensable or not. Methods. The clinicopathologic information of the 58 patients who underwent segmentectomy for ROSCCs were collected from 16 hospitals and reviewed retrospectively, compared with 98 patients who underwent lobectomy for ROSCCs. Results. Five-year survival rate of the 58 patients based on lung cancer deaths was 96.8%, and 82.6% including all causes of death. The duration of chest tube drainage in the segmentectomy group was slightly longer than in the lobectomy group. Operative mortality and the frequency of postoperative complications were not statistically different in both groups. Postoperative/preoperative vital capacity and forced expiratory volume in 1 second were higher in the segmentectomy group. Conclusions. These results suggest that segmentectomy may be an alternative for surgical therapy of carefully selected ROSCCs. More prospective studies are required to fully demonstrate clinical benefit. (C) 2001 by The Society of Thoracic Surgeons.
引用
收藏
页码:1100 / 1104
页数:5
相关论文
共 19 条
[1]  
Cortese DA, 1997, MAYO CLIN PROC, V72, P595
[2]   What kind of hilar lung cancer can be a candidate for segmentectomy with curative intent?: Retrospective clinicopathological study of completely resected roentgenographically occult bronchogenic squamous cell carcinoma [J].
Endo, C ;
Sagawa, M ;
Sato, M ;
Sakurada, A ;
Aikawa, H ;
Takahashi, S ;
Usuda, K ;
Saito, Y ;
Fujimura, S .
LUNG CANCER, 1998, 21 (02) :93-97
[3]   LOCALIZED PERIBRONCHIAL THICKENING - A CT SIGN OF OCCULT BRONCHOGENIC-CARCINOMA [J].
FOSTER, WL ;
ROBERTS, L ;
MCLENDON, RE ;
HILL, RC .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1985, 144 (05) :906-908
[4]  
Fujimura S, 2000, CANCER, V89, P2445, DOI 10.1002/1097-0142(20001201)89:11+<2445::AID-CNCR19>3.0.CO
[5]  
2-V
[6]   A PROSPECTIVE PHASE-II STUDY ON PHOTODYNAMIC THERAPY WITH PHOTOFRIN-II FOR CENTRALLY LOCATED EARLY-STAGE LUNG-CANCER [J].
FURUSE, K ;
FUKUOKA, M ;
KATO, H ;
HORAI, T ;
KUBOTA, K ;
KODAMA, N ;
KUSUNOKI, Y ;
TAKIFUJI, N ;
OKUNAKA, T ;
KONAKA, C ;
WADA, H ;
HAYATA, Y .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) :1852-1857
[7]   RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER [J].
HOLMES, CE ;
RUCKDESCHEL, JC ;
JOHNSTON, M ;
THOMAS, PA ;
DESLAURIERS, J ;
GROVER, FL ;
HILL, LD ;
FELD, R ;
GINSBERG, RJ ;
MOUNTAIN, CF ;
DZUIBAN, S ;
KIELY, M ;
MCKNEALLY, MF ;
MOORES, DWO ;
RAMNES, C ;
WAGNER, H ;
BUNN, P ;
CHU, H ;
DIENHART, D ;
HAZUKA, M ;
KINZIE, J ;
SORENSEN, J ;
VANCE, V ;
BRAUN, T ;
HOPEMAN, A ;
KANE, M ;
RUSS, P ;
WHITMAN, GJR ;
FALL, SM ;
HANSEN, DP ;
HENDERSON, RH ;
MONCRIEF, CL ;
PAULING, F ;
SIMS, J ;
TELL, D ;
WISELYCARR, S ;
ABERNATHY, CM ;
CLARK, DA ;
MCCROSKEY, B ;
MOORE, G ;
MOORE, F ;
MYERS, A ;
WHITE, M ;
BROOKS, RJ ;
BULL, M ;
JOHNSON, FB ;
NEIMYR, M ;
PAQUETTE, FR ;
SACCOMANNO, G ;
LAD, T .
ANNALS OF THORACIC SURGERY, 1995, 60 (03) :615-622
[8]  
IZBICKI JR, 1992, J THORAC CARDIOV SUR, V104, P413
[9]   OCCULT CARCINOMAS OF THE LUNG [J].
MARTINI, N ;
MELAMED, MR .
ANNALS OF THORACIC SURGERY, 1980, 30 (03) :215-223
[10]   Revisions in the International System for Staging Lung Cancer [J].
Mountain, CF .
CHEST, 1997, 111 (06) :1710-1717